Slow-K Dosing for Hypokalemia
For adults with diuretic-induced hypokalemia, Slow-K (extended-release potassium chloride) should be dosed at 20-60 mEq per day, typically given as 8 mEq tablets three times daily, with the goal of maintaining serum potassium between 4.0-5.0 mEq/L.
Dosing Algorithm
Initial Dosing
- Start with 20-40 mEq daily divided into 2-3 doses (typically 8 mEq three times daily) 1
- This translates to one 8 mEq tablet three times daily for most patients on thiazide diuretics
Monitoring Schedule
- Check serum potassium and creatinine 5-7 days after initiation 2
- Continue checking every 5-7 days until values are stable 3, 2
- Once stable, monitor every 3-6 months 2
Target Range
- Maintain serum potassium at 4.0-5.0 mEq/L (some guidelines suggest 4.5-5.0 mEq/L) 4
- This range minimizes arrhythmia risk while avoiding hyperkalemia
Clinical Context and Indications
Use Slow-K only when:
- Hypokalemia persists despite ACE inhibitor therapy in heart failure patients 3, 2
- Patient is on diuretics causing potassium depletion
- Oral potassium supplements are less effective than potassium-sparing diuretics but may be necessary 2
Critical Safety Considerations
Avoid or Use with Extreme Caution When:
- Patient is on ACE inhibitors or ARBs - this combination was historically considered dangerous and requires careful monitoring 2
- Serum creatinine >150 μmol/L or GFR <30 mL/min 2
- Baseline potassium >4.5 mEq/L 5
- Patient is taking potassium-sparing diuretics (spironolactone, amiloride, triamterene) 3, 2
Dangerous Hyperkalemia Risk
The guidelines emphasize that potassium-sparing diuretics should be avoided during ACE inhibitor initiation 3, 2. The same caution applies to potassium supplements. When both are necessary, intensive monitoring is mandatory with checks every 5-7 days initially 2.
Practical Dosing Details
Research demonstrates that 24 mEq of Slow-K given as 8 mEq tablets three times daily effectively maintains normal serum electrolytes in hypertensive patients on thiazide diuretics 1. The study showed this regimen was well-tolerated with good patient compliance.
Maximum Dosing
- Guidelines suggest potassium supplementation up to 60 mEq/day may be required 4
- However, if this much supplementation is needed, consider switching to potassium-sparing diuretics instead, as they are more effective at maintaining body potassium stores 2
When to Stop or Reduce
Immediately stop or hold if:
- Serum potassium rises >5.0 mEq/L (some use >5.5 mEq/L as threshold) 5
- Patient develops renal insufficiency with rising creatinine
- ECG changes suggesting hyperkalemia appear (peaked T waves, widened QRS) 6
Alternative Considerations
The evidence indicates that potassium-sparing diuretics are more effective than oral potassium supplements for maintaining potassium stores during diuretic treatment 2. Consider switching to spironolactone 25 mg daily, amiloride 2.5-5 mg daily, or triamterene 25-50 mg daily if:
- Patient requires >40-60 mEq/day of supplementation
- Hypokalemia persists despite adequate supplementation
- Patient has difficulty with compliance to multiple daily doses
However, these agents carry their own hyperkalemia risk and require the same intensive monitoring schedule 2.